One in eight women will develop breast cancer. Breast and ovarian cancers are complicated diseases but through the power of genomic science and medicine, HudsonAlpha Institute for Biotechnology is working to find answers that make a difference. Each day, we strive to find new breakthroughs that will bring health, healing and hope to our mothers, wives, sisters, and daughters.

HudsonAlpha’s Breakthrough Breast and Ovarian Cancer team is committed to the goal of using genomic science and state-of-the-art technology to find new breakthroughs in breast and ovarian cancers. Through collaborations with scientists around the nation, this team is working to find biomarkers that lead to earlier, more accurate diagnoses and new pathways for more effective and targeted treatments.

Our mission is to use genomics to improve health and well-being for all people. Detecting these devastating cancers earlier and developing more targeted treatments will reduce the chances of recurrence and keep our families healthy. You can support HudsonAlpha’s breast and ovarian cancer projects by clicking here.

The HudsonAlpha Foundation, a 501(c)(3) nonprofit organization, is the supporting entity for the HudsonAlpha Institute for Biotechnology. Tax-deductible contributions to the foundation are for the sole purpose of advancing the mission of the HudsonAlpha Institute for Biotechnology.

Tax identification #27-2320591